Aug 3, 2022 • 55M

Ep. 15 - "Definitely not:" COVID-19 vaccination and drug price negotiation

The FLATLINING Podcast

 
1×
0:00
-55:09
Open in playerListen on);
    Substack App
    Download MP3
    Get a private RSS link for listening
    Subscribe to The FLATLINING Podcast to get a private link for listening in your favorite podcast player. Learn about RSS.

Appears in this episode

Fulcrum Strategies
The FLATLINING Podcast brings you great healthcare analysis and discussion each week from industry experts who know their way around politics, economics, and a doctors office. Subscribe for more great content and check out the articles at www.FLATLINING.net.
Episode details
Comments
woman carrying toddler sitting on chair
Photo by CDC on Unsplash

On the FLATLINING Podcast this week, Matthew and Ron take a look at the newest data on opinions about COVID-19 vaccination for young children. More than four in ten parents say they will “definitely not” vaccinate their young child and nearly three in ten say they won’t be able to get the vaccine for their child from a place they trust. We break down the numbers.

Medicare drug price negotiation continues to be pushed through Congress, this time making its way into a reconciliation bill. It eliminates some co-insurance and caps some out-of-pocket spending. It also allows the Department of Health and Human Services to negotiate for a maximum of twenty drugs. Does this bill actually do what the Democrats claim or will this be the end of a free market economy as some Republicans claim? Or both? Or neither?

And in a Final Note: Even more surprising numbers show how few parents have actually talked to their child’s pediatrician about COVID-19 vaccines.

Share

Let us know what you think in the comments below, email us at flatlining@substack.com, or tweet Matthew or Ron.

Subscribe to the FLATLINING Podcast on Apple Podcasts, Spotify, the iHeartRadio app, Amazon Music, Google Podcasts, and Audible.

Follow Matthew (@radioHandley) and Ron (@RonHowrigon) on Twitter.

Articles mentioned in this week’s program:

KFF COVID-19 Vaccine Monitor: July 2022 - Kaiser Family Foundation

Democrats' drug pricing bill still targets plenty of blockbusters - Axios

Drug price controls would limit new medicines - Sally Pipes in the Washington Examiner

Reducing Patient Access to New Medications: Progressives Latest Medicare Price Fixing Scheme - Robert E. Moffit, Ph.D. in RealClear Health

How Would the Prescription Drug Provisions in the Senate Reconciliation Proposal Affect Medicare Beneficiaries? - Kaiser Family Foundation

Share